| Followers | 271 |
| Posts | 15407 |
| Boards Moderated | 1 |
| Alias Born | 03/28/2013 |
Friday, January 25, 2019 9:38:42 AM
https://www.youtube.com/watch?v=n3fkiwTABag
https://www.anavex.com/anavex-encouraged-by-scientific-data-confirming-sigma-1-receptors-beneficial-direct-interaction-with-cannabinoid-receptor/
“With Anavex drug candidates targeting the sigma-1 receptor, and with the mechanism of action being further validated, we are even more encouraged to advance our studies with additional neurodegenerative diseases,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. “The Company is intrigued to realize the direct link to the body’s endocannabinoid system and to proceed with potential studies with our sigma-1 drugs candidates and cannabinoids.”
Another informative study
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad140492
~A MUST WATCH DOCUMENTARY~
https://www.youtube.com/watch?v=csbJnBKqwIw
Good luck everyone $AVXL
Patience And
Perspective
Recent AVXL News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
